Fig. 2: Outcomes for the entire group. | Blood Cancer Journal

Fig. 2: Outcomes for the entire group.

From: Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study

Fig. 2

a Progression-free survival (PFS) for the entire group. b Event-free survival (EFS) for the entire group. c Overall survival (OS) for the entire group. KM est Kaplan–Meier estimates, NE not estimable, HR hazard ratio.

Back to article page